Dr Fields discusses the ongoing successful collaboration between the Florida Atlantic University and the Memorial Cancer Institute.

The institutes work together on advances in patient treatment, clinical trials, and grant funding, so far securing $4.2 million through collaborative proposals.

Increased collaboration has led to sharing data across more diverse patient populations, and a biorepository has been developed to analyse cancer treatment samples.

Dr Fields is further researching the role of the MBLAC1 protein, enhancing understanding of drug effectiveness and guiding clinical trials.